Special thanks to HER Foundation Advisory Council member, Elizabeth Lowder, MSW, LCSW, for helping develop this content. The Lindsay Clancy trial has brought renewed national attention to the devastating consequences…
The HER Foundation is thrilled to share our 2023-2024 Impact Report with our community. The past two years brought major breakthroughs in Hyperemesis Gravidarum (HG) research, expanded global awareness, and…
The HER Foundation is thrilled to have the groundbreaking research on hyperemesis gravidarum (HG) and pregnancy sickness shortlisted for the Falling Walls Science Breakthrough of the Year 2024 title in…
Are you as excited as we are about the international Hyperemesis Gravidarum (HG) conference being in the United States for the first time? ICHG 2024 happens every other year, and…
Dr. Marlena Fejzo, HER Foundation’s Research Director, Harmonia Healthcare’s Chief Scientific Officer, and an Assistant Professor at USC has been honored as one of Forbes 50 over 50: Innovation! Discover…
Kimber MacGibbon, RN, was interviewed about the financial consequences of hyperemesis gravidarum (HG) by Mike Senecal. Among the numerous challenges HG survivors face, the financial consequences are often overlooked but…
Marlena Fejzo, PhD, has been named one of TIME’s 100 most influential people in health related to her groundbreaking research on the cause of Hyperemesis Gravidarum (HG). Dr. Fejzo has…
Marlena Fejzo, PhD, and Kimber Wakefield MacGibbon’s historical timeline that sets the stage for testing novel treatments for Nausea and Vomiting during Pregnancy (NVP) and Hyperemesis Gravidarum (HG). 1988 –…
TIME named Dr. Marlena Fejzo to its annual TIME Women of the Year list, recognizing extraordinary leaders fighting for a more equal world. Read more about Dr. Fejzo’s journey: “HER…
Dr. Marlena Fejzo and a member of our ambassador council, Aijia Grammer, were interviewed by Maria Shriver on the Today Show about hyperemesis gravidarum. HG Survivors unite for awareness, change,…
